Moderna Melanoma Vaccine Trial Success

Note: This section contains information in English only.
Source: Dukascopy Bank SA
Moderna and Merck's mRNA shot met late-stage trial goals by cutting skin cancer recurrence and spread, sending Moderna shares up.

Actual Topics